focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Virgin Wines warns sales will be below City forecasts

Thu, 04th May 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Virgin Wines UK PLC - Norwich, England-based online wine retailer - Expects financial year 2023 sales to be slightly lower than market expectations, at around GBP60 million, with underlying pretax profit in the region of GBP500,000 to GBP1 million, with a profitable and cash generative fourth quarter. Thereafter, expects double digit sales growth in financial year 2024, alongside an earnings before interest, tax, depreciation and amortisation margin of around 4% to 5%, as inflationary pressures particularly on freight and glass start to ease. Reports fourth quarter trading is expected to be in line with the previous year, but adds the third quarter was affected by a reduction in order frequency through the WineBank customer membership, a period which saw an increasingly competitive environment. Encouragingly, points out cancellation and conversion rates have started to improve since the end of the first half whilst the trade rate has also recovered from its low point in November 2022.

----------

Pollen Street PLC - London, England-based asset manager - Reports net asset value at March 31 was 900 pence or GBP578 million while its tangible net asset value per share was 540p or GBP347 million. No comparison given. Says assets under management remained at GBP3.4 billion while average fee-paying AUM continued to build to GBP2.5 billion in the first quarter, up from GBP2.3 billion for 2022. Declares a dividend of 16p.

----------

Hansard Global PLC - Isle of Man-based long-term savings provider - Issues trading update for the third quarter to March 31. Says new business was GBP25.4 million, ahead of GBP18.6 million in the previous quarter and down from GBP31.4 million a year prior. Assets under administration were GBP1.12 billion, up GBP15.6 million from the end of December. Continues to make encouraging progress with distribution opportunities for its Japanese proposition, company states. Adds new business in its largest region, Middle East and Africa, rose 20.8%, while in Latin America new business was down 9.5%.

----------

Forward Partners Group PLC - London-based early-stage technology-focused investor - Reports revenue in the year to December 31 of GBP509,000 down from GBP826,000 a year prior with a pretax loss of GBP43.1 million compared to a profit of GBP16.5 million. Net asset value at period end was 72 pence down from 104p a year before. Remains confident that healthy returns can be generated from the investment in early-stage UK startups over the long-term.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Reports pretax loss in the year to January 31 of GBP9.8 million widened from GBP9.5 million a year before on broadly unchanged revenue of GBP475,000 compared to GBP477,000. Basic and diluted earnings per share was 1.54 pence compared to 1.65p. Says well-positioned to advance pipeline of first-in-class preclinical RNAi candidates across multiple therapeutic areas, making significant progress in just one year. Notes increased losses mainly attributable to increased R&D expenditure reflecting further progress and development of its business strategy. Explains company has sufficient funds to continue in operational existence for at least 12 months from the signing of these financial statements.

----------

Let's Explore Group PLC - Manchester, England-based virtual reality entertainment company, formerly called Immotion Group PLC - Reports pretax loss from continuing operations in the year to December 31 of GBP1.9 million widened from GBP1.8 million on reduced revenue of GBP796,000, down from GBP2.5 million. Basic loss per share totalled 0.46 pence compared to 0.43p a year prior. Says group revenue from total operations increased 23% to GBP11.6 million from GBP9.4 million while adjusted earnings before interest, tax, depreciation and amortisation from total operations rose 51% to GBP1.4 million from GBP0.9 million. Notes since the year end the group has sold its largest business, Location Based Entertainment for around USD25 million and a smaller subsidiary, Uvisan.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Jul 2021 13:47

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

Read more
9 Jun 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
2 Jun 2021 09:42

E-therapeutics brings in Alison Gallafent as head of IP

(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.

Read more
14 May 2021 14:20

E-therapeutics raises £22.5m to expand capabilities and pipeline

(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.

Read more
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:48

e-Therapeutics raises GBP23 million to expand capability and pipeline

e-Therapeutics raises GBP23 million to expand capability and pipeline

Read more
13 May 2021 17:52

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

Read more
13 May 2021 16:40

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

Read more
13 May 2021 10:29

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

Read more
6 May 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
23 Apr 2021 11:31

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

Read more
23 Apr 2021 11:29

e-Therapeutics gets two payments from Galapagos under collaboration

e-Therapeutics gets two payments from Galapagos under collaboration

Read more
23 Apr 2021 10:18

E-therapeutics to receive two milestone payments from Galapagos

(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.

Read more
29 Mar 2021 15:13

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.